Related references
Note: Only part of the references are listed.Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor Responses
Denarda Dangaj et al.
CANCER RESEARCH (2013)
TLR3 agonists and proinflammatory antitumor activities
Sherven Sharma et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
Salvatore Maria Corsello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
Stephen R. Goding et al.
JOURNAL OF IMMUNOLOGY (2013)
New checkpoint inhibitors ride the immunotherapy tsunami
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2013)
Advances in targeting cell surface signalling molecules for immune modulation
Sheng Yao et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901
Steffen Walter et al.
ONCOIMMUNOLOGY (2013)
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
Oscar M. Pello et al.
BLOOD (2012)
Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells
Helen Conroy et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
Adam T. Waickman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Immunotherapy with PI3K Inhibitor and Toll- Like Receptor Agonist Induces IFN-γ+IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors
Neil A. Marshall et al.
CANCER RESEARCH (2012)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Macrophage-Induced Tumor Angiogenesis Is Regulated by the TSC2-mTOR Pathway
Wei Chen et al.
CANCER RESEARCH (2012)
Depletion of Tregs in vivo: a promising approach to enhance antitumor immunity without autoimmunity
Rena Morita et al.
IMMUNOTHERAPY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development
S. M. Pyonteck et al.
ONCOGENE (2012)
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
Hiroaki Shime et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
TAMable tumor-associated macrophages in response to innate RNA sensing
Tsukasa Seya et al.
ONCOIMMUNOLOGY (2012)
Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer
Ende Zhao et al.
ONCOIMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
Natasa Obermajer et al.
BLOOD (2011)
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
Bastian Hoechst et al.
BLOOD (2011)
Improving cancer immunotherapy by targeting tumor-induced immune suppression
Trina J. Stewart et al.
CANCER AND METASTASIS REVIEWS (2011)
Targeting Regulatory T Cells in Cancer
William L. Byrne et al.
CANCER RESEARCH (2011)
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
Mitsugu Fujita et al.
CANCER RESEARCH (2011)
Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages
Yukio Fujiwara et al.
CANCER SCIENCE (2011)
Alternative activation of macrophages by IL-4 requires SHIP degradation
Shelley B. Weisser et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Cell Surface Signaling Molecules in the Control of Immune Responses: A Tide Model
Yuwen Zhu et al.
IMMUNITY (2011)
Kruppel-like factor 4 regulates macrophage polarization
Xudong Liao et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
Xinmei Zhu et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer
Jingting Jiang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
David Coe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
Suzanne Ostrand-Rosenberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
Andrew L. Doedens et al.
CANCER RESEARCH (2010)
An Ets2-Driven Transcriptional Program in Tumor-Associated Macrophages Promotes Tumor Metastasis
Tahera Zabuawala et al.
CANCER RESEARCH (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
Jennifer S. Ko et al.
CANCER RESEARCH (2010)
Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
Christy Ralph et al.
CLINICAL CANCER RESEARCH (2010)
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2010)
A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
Krithika N. Kodumudi et al.
CLINICAL CANCER RESEARCH (2010)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
Building on dendritic cell subsets to improve cancer vaccines
Karolina Palucka et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages
Justin P. Edwards et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Phase II Study of the Anti-Cytotoxic T-Lymphocyte-Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
Ki Y. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice
Noelia Casares et al.
JOURNAL OF IMMUNOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment
G-One Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Emerging Toxicity Profiles of Anti-CTLA-4 Antibodies Across Clinical Indications
Anna Maria Di Giacomo et al.
SEMINARS IN ONCOLOGY (2010)
Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
Andrew J. Rech et al.
CANCER VACCINES (2009)
Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma
W. Elliot Love et al.
ARCHIVES OF DERMATOLOGY (2009)
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
Constantin N. Baxevanis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
Taku Nagai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Folate Receptor β Is Expressed by Tumor-Associated Macrophages and Constitutes a Marker for M2 Anti-inflammatory/Regulatory Macrophages
Amaya Puig-Kroeger et al.
CANCER RESEARCH (2009)
The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
Junko Ozao-Choy et al.
CANCER RESEARCH (2009)
Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
Hong Xin et al.
CANCER RESEARCH (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Therapeutic targeting of myeloid-derived suppressor cells
Stefano Ugel et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
Yoshiaki Kubota et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Inflammation enhances myeloid-derived suppressor cell crosstalk by signaling through Toll-like receptor 4
Stephanie K. Bunt et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia
Carl L. Manthey et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Regulated and Multiple miRNA and siRNA Delivery Into Primary Cells by a Lentiviral Platform
Mario Amendola et al.
MOLECULAR THERAPY (2009)
The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
Kosuke Mizutani et al.
NEOPLASIA (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages
Koji Hiraoka et al.
CANCER SCIENCE (2008)
The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
Paola Allavena et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Anti-Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment
Lawrence Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
Transient T cell depletion causes regression of melanoma metastases
Mary Ann Rasku et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Foxp3 expression in human cancer cells
Vaios Karanikas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma
Nathan R. Miselis et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours
H. Conroy et al.
ONCOGENE (2008)
Macrophage polarization in tumour progression
Antonio Sica et al.
SEMINARS IN CANCER BIOLOGY (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova et al.
CANCER RESEARCH (2007)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
S. Farzana Hussain et al.
CANCER RESEARCH (2007)
Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages
Toshihiko Suzuki et al.
PLOS PATHOGENS (2007)
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
Hyun-Jeong Ko et al.
CANCER RESEARCH (2007)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
MyD88-dependent expansion of an immature GR-1+ CD11b+ population induces T cell suppression and Th2 polarization in sepsis
Matthew J. Delano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells
Pratima Sinha et al.
CANCER RESEARCH (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors
Pilar Nava-Parada et al.
CANCER RESEARCH (2007)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Clodronate-liposome-mediated depletion of tumour-associated macrophages:: a new and highly effective antiangiogenic therapy approach
S. M. Zeisberger et al.
BRITISH JOURNAL OF CANCER (2006)
Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor:: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2006)
Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice
Damia Tormo et al.
CANCER RESEARCH (2006)
Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides
Heather L. Wilson et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2006)
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
I Kryczek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts
P Paulus et al.
CANCER RESEARCH (2006)
Regulatory T cells and toll-like receptors in tumor immunity
RF Wang et al.
SEMINARS IN IMMUNOLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis
P Sinha et al.
CANCER RESEARCH (2005)
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression
P Sinha et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
K Ko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
Toll-like, receptor 8-mediated reversal of CD4+ regulatory T cell function
GY Peng et al.
SCIENCE (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
C De Santo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
DE Speiser et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease
P Sinha et al.
JOURNAL OF IMMUNOLOGY (2005)
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
DMR Lathers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals
LH Zou et al.
CANCER RESEARCH (2004)
Regulatory T cells: Friend or foe in immunity to infection?
KHG Mills
NATURE REVIEWS IMMUNOLOGY (2004)
CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction
N Garbi et al.
JOURNAL OF IMMUNOLOGY (2004)
Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance
YP Yang et al.
NATURE IMMUNOLOGY (2004)
Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides
CA Akdis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells
C Pasare et al.
SCIENCE (2003)
Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells
DI Gabrilovich et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
